Search

Your search keyword '"Seron, Daniel"' showing total 252 results

Search Constraints

Start Over You searched for: Author "Seron, Daniel" Remove constraint Author: "Seron, Daniel"
252 results on '"Seron, Daniel"'

Search Results

1. A Machine Learning-Driven Virtual Biopsy System For Kidney Transplant Patients

4. Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group.

7. Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis

10. Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study

12. Derivation and external validation of the SIMPLICITY score as a simple immune-based risk score to predict infection in kidney transplant recipients

14. Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant

20. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial

21. Compliance to Multidisciplinary Lifestyle Intervention Decreases Blood Pressure in Patients with Resistant Hypertension: A Cross-Sectional Pilot Study

22. Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes

23. Treatment of early borderline lesions in low immunological risk kidney transplant patients: a Spanish multicenter, randomized, controlled parallel-group study protocol: the TRAINING study

24. NAFLD association with renal impairment in type 2 diabetes patients

26. Different Patterns of Risk Factors for Mortality according Recipient Age after Renal Transplantation. A Multicenter and Prospective Study at Ten Years in the Clinical Practice

27. Apolipoprotein A-Ib as Biomarker of FSGS Recurrence After Kidney Transplantation: Diagnostic Performance in a Prospective Cohort and Assessment of its Prognostic Value

28. Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation

30. Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation

32. The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection

38. Clinical Relevance of Corticosteroid Withdrawal on Graft Histological Lesions in Low-Immunological-Risk Kidney Transplant Patients

39. Impact of HLA Mismatching on Early Subclinical Inflammation in Low-Immunological-Risk Kidney Transplant Recipients

41. Progression of Interstitial Fibrosis and Tubular Atrophy in Low Immunological Risk Renal Transplants Monitored by Sequential Surveillance Biopsies: The Influence of TAC Exposure and Metabolism

42. A Rejection Gene Expression Score in Indication and Surveillance Biopsies Is Associated with Graft Outcome

45. Secondary antibody deficiency is associated with development of infection in kidney transplantation: Results of a multicenter study

46. PROGRESSION OF RENAL DISEASE IN RENAL TRANSPLANT RECIPIENTS: RO-259

47. THE CRITICAL ROLE OF RENAL FUNCTION, PROTEINURIA AND CARDIOVASCULAR DISEASE ON THE RESULTS AFTER RENAL TRANSPLANTATION.A PROSPECTIVE MULTICENTRE STUDY AT FIVE YEARS ACCORDING RECIPIENT AGE: O-213

50. Cellular Immunity to Predict the Risk of Cytomegalovirus Infection in Kidney Transplantation: A Prospective, Interventional, Multicenter Clinical Trial

Catalog

Books, media, physical & digital resources